super high-flux hemodialysis

DEVICE2 trials

Sponsors

Mahidol University, Faculty of medicine, Naresuan University

Conditions

End Stage Renal DiseaseEnd stage kidney disease required hemodialysis (Prevalence case) super high-flux hemodialysis nutrition assessment RNA sequencing middle molecule uremic toxin protein bound uremic toxin

Phase 3

A prospective cohort study of nutritional status and uremic toxin removal during long-term periods of super high-flux hemodialysis in chronic hemodialysis patients and the effect of RNA sequencing on peripheral blood mononuclear cells

Active, not recruitingTCTR20210510002

Faculty of medicine, Naresuan UniversityEnd stage kidney disease required hemodialysis (Prevalence case) super high-flux hemodialysis nutrition assessment RNA sequencing middle molecule uremic toxin protein bound uremic toxin

Start: 2021-05-09Target: 15Updated: 2026-08-03

Unknown Phase

Comparison of Efficacy in Removal of Advanced Glycation End Products (AGEs) Between Super High-flux Hemodialysis and Postdilution Online Hemodiafiltration: A Single-center, Prospective, Open-label, Crossover Randomized Controlled Trial

Mahidol UniversityEnd Stage Renal Disease

Start: 2022-04-04End: 2023-06-30Updated: 2023-03-21